MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202547094324 A) filed by Institute For Stem Cell Science And Regenerative Medicine; and Council Of Scientific And Industrial Research, Bengaluru, India, on Oct. 1, for 'methods and platform involving the use of a nucleo-cytoplasmic form of protein lysine methyltransferase ehmt1 n/c.'
Inventor(s) include Deshpande, Shravanti Rampalli; and Biligiri, Kriti Kestur.
The application for the patent was published on Oct. 31, under issue no. 44/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a a method of modulating the activity of EHMT1 N/C and its role as a pro-viral factor at the interface of host-virus interactions. The present disclosure also relates to a method of inhibiting/reducing viral replication, use of molecules targeting EHMT1 N/C for inhibiting viral replication for treating viral infection, a method of treating viral infection and a method/platform for screening anti-viral agents/molecules."
The patent application was internationally filed on Mar. 01, 2024, under International application No.PCT/IN2024/050221.
Disclaimer: Curated by HT Syndication.
